Log in to your Inderes Free account to see all free content on this page.
ODI Pharma
4.02 SEK
+12.92 %
Less than 1K followers
ODI
Spotlight Stock Market
Biotechnology & Pharmaceuticals
Health Care
Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
Valuation
Income statement
Quarter data
Quarter data
Financial statements, revenue, EBIT, valuation metrics, and quarterly estimates for ODI Pharma
| 2024 | Q1/25 | Q2/25 | Q3/25 | Q4/25 | 2025 | Q1/26 | Q2/26 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | 22.5 | 0.1 | 2.9 | 0.0 | 3.1 | 6.0 | 10.9 | |
| EBITDA | -24.2 | -1.3 | -2.3 | -0.2 | -1.5 | -5.2 | 0.1 | 1.5 |
| EBIT | -24.2 | -1.3 | -2.3 | -0.2 | -1.5 | -5.2 | 0.1 | 1.5 |
| EBIT-% | -107.8 % | -957.1 % | -7.5 % | -15,200.0 % | -168.5 % | 1.9 % | 13.6 % | |
| Profit before taxes | 0.5 | -1.5 | -2.6 | -0.3 | -1.7 | -5.9 | -0.0 | 1.3 |
| Net income | 0.4 | -1.5 | -2.6 | -0.3 | -1.7 | -5.9 | -0.0 | 1.3 |
Login required
This content is only available for logged in users